Results 231 to 240 of about 45,078 (268)

Bivalent Cholera and Typhoid Vaccine

Drugs, 1999
The live attenuated vaccine strains Vibrio cholerae CVD 103-HgR and Salmonella typhi Ty21a can be combined into an oral bivalent vaccine without compromising the immunogenicity of the individual vaccine strains. Seroconversion rates of 87 to 94% for Inaba vibriocidal antibodies and 72 to 91% for anti-S.
Stuart Noble, Rachel H. Foster
openaire   +3 more sources

The first British reference preparations of cholera vaccine (Inaba) and of cholera vaccine (Ogawa)

Journal of Biological Standardization, 1977
Abstract An international collaborative study was undertaken to assess the suitability of a preparation of cholera vaccine (Inaba) and one of cholera vaccine (Ogawa) to serve as British reference preparations. Eight laboratories participated in the study.
Valerie Seagroatt, Annette W. Ford
openaire   +3 more sources

Molecular design of cholera vaccines

Vaccine, 1992
Cholera is still a serious public health problem in developing countries, particularly those in tropical regions. This has stimulated considerable research into the molecular analysis of pathogenesis resulting in the identification of a number of critical components required for both colonization of the gut mucosa and the disease symptoms.
openaire   +3 more sources

Embracing Oral Cholera Vaccine — The Shifting Response to Cholera

New England Journal of Medicine, 2014
Despite evidence of the safety and efficacy of oral cholera vaccines, they were not included in the prevention package during the 2010 Haitian cholera epidemic. But some major obstacles to the use of OCVs in cholera outbreaks have since been overcome.
Vanessa Rouzier, Jean W. Pape
openaire   +3 more sources

Designing spatial and temporal control of vaccine responses

Nature Reviews Materials, 2021
Shih Hao Ou, Wei Luo, Bali Pulendran
exaly  

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology, 2021
Aakash Desai, Justin F Gainor, Aparna M Hegde   +2 more
exaly  

Cholera vaccines

The Lancet Infectious Diseases, 2007
openaire   +2 more sources

SARS-CoV-2 variants, spike mutations and immune escape

Nature Reviews Microbiology, 2021
William T Harvey, Alessandro Maria Carabelli, Benjamin C Jackson   +2 more
exaly  

Cholera Vaccines

2018
John D. Clemens, Jan Holmgren, Firdausi Qadri, Gopinath Balakrish Nair, Sachin N. Desai   +4 more
openaire   +2 more sources

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation

Ca-A Cancer Journal for Clinicians, 2020
Robert A Smith
exaly